Vis enkel innførsel

dc.contributor.authorMi, Fenglingen_US
dc.contributor.authorJiang, Guangluen_US
dc.contributor.authorDu, Jianen_US
dc.contributor.authorLi, Liangen_US
dc.contributor.authorYue, Wentaoen_US
dc.contributor.authorHarries, Anthony D.en_US
dc.contributor.authorHinderaker, Sven Gudmunden_US
dc.contributor.authorLin, Yanen_US
dc.date.accessioned2015-04-15T08:50:56Z
dc.date.available2015-04-15T08:50:56Z
dc.date.issued2014-05-19eng
dc.identifier.issn1654-9880
dc.identifier.urihttps://hdl.handle.net/1956/9788
dc.description.abstractBackground: China has a high burden of drug-resistant tuberculosis (TB) and diabetes mellitus (DM). Objective: The objectives of this study were to determine the following in patients with culture-confirmed TB: 1) demographic characteristics and disease patterns in relation to the presence or absence of type 2 diabetes and 2) presence or absence of drug resistance to isoniazid (INH), rifampicin (RMP) or both in relation to duration of diabetes and control of diabetes. Design: This is a cross-sectional and retrospective study involving record reviews. Results: There were 621 patients with culture-positive TB, of whom 187 (30%) had previously known or new type 2 diabetes. In those with diabetes, there was a significantly higher proportion of males, persons aged ≥35 years and patients registered with new TB (p<0.05). Prevalence of multidrug-resistant TB (MDR-TB) was 6.2% in new patients (N=422) and 62.3% in previously treated patients (N=199), with no significant differences between those with and without diabetes. In patients with diabetes, there was no association of drug resistance with diabetes duration or disease control [assessed by fasting blood glucose (FBG) at 1 week]. Conclusion: A high proportion of patients with TB in a tertiary health facility, Beijing, China, had diabetes, but there was no association between type 2 diabetes and drug-resistant TB. Further prospective studies are needed to confirm these findings.en_US
dc.language.isoengeng
dc.publisherCo-Action Publishingeng
dc.rightsAttribution CC BYeng
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/eng
dc.subjectDiabetes mellituseng
dc.subjectdiabetes durationeng
dc.subjectdiabetes controleng
dc.subjectTuberculosiseng
dc.subjectmultidrug-resistant tuberculosiseng
dc.subjectChinaeng
dc.titleIs resistance to anti-tuberculosis drugs associated with type 2 diabetes mellitus? A register review in Beijing, Chinaen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2015-04-01T09:51:28Zen_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2014 Fengling Mi et al.
dc.source.articlenumber24022
dc.identifier.doihttps://doi.org/10.3402/gha.v7.24022
dc.identifier.cristin1162916
dc.source.journalGlobal health action
dc.source.407
dc.subject.nsiVDP::Medical sciences: 700::Clinical medical sciences: 750::Endocrinology: 774eng
dc.subject.nsiVDP::Medical sciences: 700::Basic medical, dental and veterinary sciences: 710::Clinical pharmacology: 739eng
dc.subject.nsiVDP::Medical sciences: 700::Clinical medical sciences: 750::Lung diseases: 777eng
dc.subject.nsiVDP::Medisinske fag: 700::Klinisk medisinske fag: 750::Endokrinologi: 774nob
dc.subject.nsiVDP::Medisinske fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Klinisk farmakologi: 739nob
dc.subject.nsiVDP::Medisinske fag: 700::Klinisk medisinske fag: 750::Lungesykdommer: 777nob


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution CC BY
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution CC BY